Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 2
2017 2
2018 1
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529.
Mitra D, Hong TS, Horick N, Rose B, Drapek LN, Blaszkowsky LS, Allen JN, Kwak EL, Murphy JE, Clark JW, Ryan DP, Cusack JC, Bordeianou LG, Berger DL, Wo JY. Mitra D, et al. Adv Radiat Oncol. 2017 Feb 6;2(2):110-117. doi: 10.1016/j.adro.2017.01.009. eCollection 2017 Apr-Jun. Adv Radiat Oncol. 2017. PMID: 28740921 Free PMC article.
Assessing survival benefit when treatment delays disease progression.
Schoenfeld DA, Finkelstein DM. Schoenfeld DA, et al. Clin Trials. 2016 Jun;13(3):352-7. doi: 10.1177/1740774515625990. Epub 2016 Feb 22. Clin Trials. 2016. PMID: 26908538 Free PMC article.
Physical and psychological health in rare cancer survivors.
Horick NK, Manful A, Lowery J, Domchek S, Moorman P, Griffin C, Visvanathan K, Isaacs C, Kinney AY, Finkelstein DM. Horick NK, et al. J Cancer Surviv. 2017 Feb;11(1):158-165. doi: 10.1007/s11764-016-0573-0. Epub 2016 Oct 19. J Cancer Surviv. 2017. PMID: 27761785 Free PMC article.
Physical symptoms in long-term survivors of rare cancer.
Horick NK, Muzikansky A, Gutierrez HL, Boyd KL, Finkelstein DM. Horick NK, et al. J Cancer Surviv. 2018 Dec;12(6):835-842. doi: 10.1007/s11764-018-0721-9. Epub 2018 Oct 12. J Cancer Surviv. 2018. PMID: 30315392 Free PMC article.
Are rare cancer survivors at elevated risk of subsequent new cancers?
Finkelstein DM, Horick NK, Ramchandani R, Boyd KL, Rana HQ, Bychkovsky BL. Finkelstein DM, et al. BMC Cancer. 2019 Feb 21;19(1):166. doi: 10.1186/s12885-019-5358-1. BMC Cancer. 2019. PMID: 30791872 Free PMC article.
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D, Horick NK, Brackett DG, Mouw KW, Hornick JL, Ferrone S, Hong TS, Mamon H, Clark JW, Parikh AR, Allen JN, Ryan DP, Ting DT, Deshpande V, Wo JY. Mitra D, et al. Oncologist. 2019 Jun;24(6):e275-e283. doi: 10.1634/theoncologist.2018-0794. Epub 2019 Feb 12. Oncologist. 2019. PMID: 30755500 Free PMC article.
Feedback